Register
FDA Okays First Newborn Screening Test for Duchenne MD |
Clinical News
eMediNexus Coverage from: 
FDA Okays First Newborn Screening Test for Duchenne MD
eMediNexus,  13 December 2019
remove_red_eye 526 Views
#Orthopedics #Pathology and Lab Medicine #Pediatrics #Pharmacist #Public Health #Rheumatology

1 Read Comments                

The US Food and Drug Administration (FDA) has authorized the marketing of the first newborn screening test for Duchenne muscular dystrophy (DMD), the agency announced.

The GSP Neonatal Creatine Kinase-MM kit (PerkinElmer) measures levels of creatine kinase (CK) from dried blood samples collected from a draw from an infants heel 24 to 48 hours after birth. Although high levels may indicate the presence of DMD, the FDA notes that the findings would still need to be confirmed with other testing methods, such as muscle biopsies or genetic tests… (Medscape)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now